首页 › 基金 › Paradigm Biocapital Advisors LP › MANE
Paradigm Biocapital Advisors LP 对 MANE 的持仓历史
VERADERMICS INC · 医疗保健
Paradigm Biocapital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 MANE(VERADERMICS INC)310,060 股,市值约 US$37.6M,约占其申报组合的 0.75%,在其申报持仓中市值排名第 20 位。 Paradigm Biocapital Advisors LP 最近 3 个申报季度中有 2 个季度披露了 MANE 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Paradigm Biocapital Advisors LP 对 MANE 的持仓演变
Paradigm Biocapital Advisors LP 于 Q1 2026 首次披露 MANE 持仓:525,000 股(约 US$33.2M)。 该持仓在 Q3 2026 达到峰值 310,060 股,市值约 US$37.6M。 在 2 次申报中,Paradigm Biocapital Advisors LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 310,060 股、市值约 US$37.6M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 525.00K | $33.15M | 新进 |
| Q3 2026 | 310.06K | $37.59M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MANE 与 13F 数据
MANE(VERADERMICS INC)属于医疗保健行业。我们追踪的基金中还有 150 只申报持有 MANE,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$230.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MANE 的基金
- MONTANOVA CAPITAL, LLC 4.17M 股 · $512.53M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.40M 股 · $295.29M · Q2 2026
- Deep Track Capital, LP 1.90M 股 · $230.34M · Q3 2026
- Siren, L.L.C. 1.32M 股 · $160.54M · Q3 2026
- Maverick 资本 789.98K 股 · $97.12M · Q2 2026
- MAVERICK CAPITAL LTD 789.98K 股 · $97.12M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 731.15K 股 · $89.89M · Q2 2026
- EMERALD ADVISERS, LLC 332.39K 股 · $40.30M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 225.55K 股 · $27.34M · Q3 2026
- Logos Global Management LP 170.00K 股 · $20.61M · Q3 2026
- Kalehua Capital Management LLC 145.69K 股 · $17.66M · Q3 2026
- Sofinnova Investments, Inc. 144.05K 股 · $17.46M · Q3 2026
更多关于 Paradigm Biocapital Advisors LP
常见问题
How long has Paradigm Biocapital Advisors LP held MANE?
Paradigm Biocapital Advisors LP has disclosed MANE holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Paradigm Biocapital Advisors LP's current position in MANE?
As of Q3 2026, Paradigm Biocapital Advisors LP holds 310.06K shares of MANE (VERADERMICS INC), valued at $37.59M, representing 0.75% of its reported portfolio and ranking #20.
Has Paradigm Biocapital Advisors LP been buying or selling MANE?
In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP newly opened its position in MANE. The position peaked in Q3 2026 at 310.06K shares.
Which other funds hold MANE?
Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 150 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.